USP Chapter <797>: Improving Sterile Compounding Practices

Activity Preview

The U.S. Pharmacopeia (USP) General Chapter <797> outlines standards for compounding quality sterile preparations—including the compounding process, facilities, equipment, components, documentation, quality controls, and training. Does your operation comply with USP <797>?

Learning Objectives

At the completion of this knowledge-based activity, participants will be able to:

  1. Discuss the purpose of the U.S. Pharmacopeia (USP) General Chapter <797>.
  2. Identify common preparations that fall under USP <797> as sterile products.
  3. Identify personnel training and facility elements that are needed to comply with USP <797>.
  4. Discuss common mistakes that are made when trying to become compliant with USP <797>.

Activity type: Knowledge-based
Target Audience: Pharmacists
Learning Level: 2

Accreditation Information

ACPE Logo

The American Pharmacists Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The following archived webinar is approved for 1 contact hour of CPE credit (0.1 CEUs). The ACPE Universal Activity Number for this activity is 0202-0000-21-008-H07-P

To obtain credit for USP Chapter <797>: Improving Sterile Compounding Practices participants will need to watch the archived webinar, complete the evaluation, and then CLAIM credit. Participants need to have a valid pharmacist.com and CPE Monitor/NABP ID account to claim credit. After credit has been claimed, please visit CPE monitor for your transcript.

Initial release date: March 15, 2021
Expiration date: March 15, 2024 - No credit granted after this date

Development

USP Chapter <797>: Improving Sterile Compounding Practices is an activity for pharmacists developed by the American Pharmacists Association. © 2021 American Pharmacists Association

Disclosures

Speaker disclosures will be provided at the time of the seminar, and APhA’s editorial staff declare no conflicts of interest or financial interests in any product or service mentioned in this activity, including grants, employment, gifts, stock holdings, and honoraria. For a complete list of APhA staff disclosures, visit the APhA website at www.pharmacist.com/apha-disclosures

Conflicts of interest have been resolved through content review by Helen Sairany, BA, PharmD, MBA, BCACP, Director of Content Development & Partnership at the American Pharmacists Association. 

Fee

This learning product is a component of the APhA2021 Virtual Education package.

System Requirements

Computer and internet access are required to complete this activity.  Please visit our website to view the Technology System Requirements in order to have a positive learning experience.

Credit Information

Activity Number Credit Amount Accreditation Period
ACPE# 0202-0000-21-008-H07-P 0.1 CEUs March 15, 2021 - March 15, 2024